Summary: In this interview we speak with two prostate cancer experts, Andrew J. Armstrong and Tomasz M. Beer, both of whom are actively involved in the research and clinical trials of novel agents, on the topic of newly available and upcoming treatment options for patients with castration-resistant prostate cancer.
